Chang Chien-Hung, Ku Chi-Ming, Ger Tzong-Rong, Lin Wen-Piao
Department of Neurology, Chang Gung Memorial Hospital, Linkou Branch, College of Medicine, Chang Gung University, Taoyuan 33305, Taiwan.
Department and Graduate Institute of Electrical Engineering, College of Engineering, Chang Gung University, Taoyuan 33305, Taiwan.
Diagnostics (Basel). 2025 Jun 23;15(13):1590. doi: 10.3390/diagnostics15131590.
: Acute ischemic stroke (AIS) remains a leading cause of mortality and disability worldwide. Accurate evaluation of collateral circulation is essential for predicting outcomes following endovascular thrombectomy (EVT). However, conventional visual collateral scoring (vCS) based on multiphase CT angiography (mCTA) is limited by subjectivity and inter-observer variability. This preliminary study introduces the multiphase quantitative collateral score (mqCS), a novel imaging biomarker designed to provide an objective and reproducible assessment of both the morphological extent and temporal dynamics of collateral flow. : In this exploratory study, 54 AIS patients treated with EVT were retrospectively analyzed. Collateral status was evaluated using both vCS (graded by two blinded neuroradiologists) and mqCS, derived from mCTA-based fractal dimension (FD) and delay indicator (DI) metrics. Logistic regression and receiver operating characteristic (ROC) analyses were performed to assess the predictive value of each scoring system for favorable 90-day functional outcomes (modified Rankin scale, mRS ≤ 2). : The mqCS was significantly associated with favorable outcomes. Patients with mqCS ≥ 0.8674 had significantly higher odds of achieving favorable outcomes (adjusted OR = 5.98, 95% CI: 1.38-25.93, = 0.017; AUC = 0.80). In comparison, the visual collateral score (vCS) showed a lower adjusted predictive value (adjusted OR = 2.84, 95% CI: 1.17-6.89, = 0.02; AUC = 0.79). Patients in the highest mqCS quartiles (Q3-Q4) exhibited significantly better recovery rates (69%, < 0.01). : This proof-of-concept study suggests that mqCS provides a potentially more objective and robust alternative to visual scoring for collateral assessment in AIS. By integrating structural and temporal characteristics, mqCS enhances outcome prediction and may inform EVT decision-making, particularly in borderline cases. These preliminary findings warrant validation in larger, prospective cohorts and support its potential integration into automated imaging platforms.
急性缺血性卒中(AIS)仍然是全球范围内导致死亡和残疾的主要原因。准确评估侧支循环对于预测血管内血栓切除术(EVT)后的预后至关重要。然而,基于多期CT血管造影(mCTA)的传统视觉侧支评分(vCS)受主观性和观察者间差异的限制。这项初步研究引入了多期定量侧支评分(mqCS),这是一种新型成像生物标志物,旨在对侧支血流的形态范围和时间动态提供客观且可重复的评估。
在这项探索性研究中,对54例接受EVT治疗的AIS患者进行了回顾性分析。使用vCS(由两名盲法神经放射科医生分级)和mqCS评估侧支状态,mqCS源自基于mCTA的分形维数(FD)和延迟指标(DI)度量。进行逻辑回归和受试者工作特征(ROC)分析,以评估每个评分系统对90天良好功能结局(改良Rankin量表,mRS≤2)的预测价值。
mqCS与良好结局显著相关。mqCS≥0.8674的患者实现良好结局的几率显著更高(调整后的OR = 5.98,95% CI:1.38 - 25.93,P = 0.017;AUC = 0.80)。相比之下,视觉侧支评分(vCS)显示出较低的调整后预测价值(调整后的OR = 2.84,95% CI:1.17 - 6.89,P = 0.02;AUC = 0.79)。mqCS最高四分位数(Q3 - Q4)的患者表现出显著更好的恢复率(69%,P < 0.01)。
这项概念验证研究表明,mqCS为AIS侧支评估的视觉评分提供了一种潜在更客观、更可靠的替代方法。通过整合结构和时间特征,mqCS增强了结局预测能力,并可能为EVT决策提供信息,特别是在临界病例中。这些初步发现值得在更大的前瞻性队列中进行验证,并支持其潜在整合到自动化成像平台中。